Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by Staghorn69on Jul 13, 2017 11:00am
155 Views
Post# 26464698

RE:RE:FDA moving along....

RE:RE:FDA moving along....We aren't even waiting for approval....  We are waiting to hear WHAT kind of review FOR approval we'll get...  A sad state of affairs as this FDA trip has so far been a failure.  Whether that's on the FDA due to "internal issues" or due to PLI incompetence in filing, I guess we won't really know but I know where my money is on that one.  In the meantime, the stock is drifting lower.  The ONLY things that save us now is a FDA priority review announcement OR a China Deal with excellent terms.  If we see days of accumulation prior to any announcement, like all the previous NRs in the past couple years, I'm going to the regulators.  As for the China Deal, anything lucrative is basically off the table in my mind given that the China Deal gives 25% of 4050 away for what? $30 Mil???  Just for the right to do the deal in China!!  What a joke, and they can't even get that deal done.  So much for those massive 4050 valuations fluffed out in the vaunted pumping "Valuation Reports"...  Poof.
Bullboard Posts